These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37475936)

  • 1. Retracted: Effects of Cisplatin Combined with Metformin on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9856726. PubMed ID: 37475936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Cisplatin Combined with Metformin on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells.
    Shi L; Mei Y; Duan X; Wang B
    Comput Math Methods Med; 2022; 2022():2056247. PubMed ID: 35422875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9.
    Sun XJ; Zhang P; Li HH; Jiang ZW; Jiang CC; Liu H
    Asian Pac J Cancer Prev; 2014; 15(9):4019-23. PubMed ID: 24935589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9798503. PubMed ID: 37416222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts.
    Chen Z; Zeng Z; Zhu S; Zeng Y; Lin Q; Luo L; Hong X
    Sci Rep; 2021 Jan; 11(1):1040. PubMed ID: 33441838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation.
    Sun Y; Chen X; Zhou Y; Qiu S; Wu Y; Xie M; Zhu G; Liang S; Li H; Zhou D; Ju Z; Wang F; Han F; Wang Z; Wang R
    Int J Med Sci; 2020; 17(16):2416-2426. PubMed ID: 33029084
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of tunicamycin combined with cisplatin on proliferation and apoptosis of human nasopharyngeal carcinoma cells in vitro].
    Song L; Ma L; Zhang X; Jiang Z; Liu H; Jiang C
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):766-71. PubMed ID: 22699051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9812746. PubMed ID: 37387977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9781420. PubMed ID: 37416142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors.
    Neuroscience CIA
    Comput Intell Neurosci; 2022; 2022():9854614. PubMed ID: 36601276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] miR‑639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma.
    Wang YH; Yin YW; Zhou H; Cao YD
    Oncol Lett; 2024 Feb; 27(2):76. PubMed ID: 38192678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retracted] MicroRNA‑379 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by targeting tumor protein D52.
    Zhao X; Chu J
    Exp Ther Med; 2024 Jul; 28(1):288. PubMed ID: 38827475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9805178. PubMed ID: 37387906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9761286. PubMed ID: 37416255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9804984. PubMed ID: 37416199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Prediction of Changes in Tumor Regression during Radiotherapy for Nasopharyngeal Carcinoma by Using the Computed Tomography-Based Radiomics.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9809608. PubMed ID: 37547642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Analysis of the Molecular Mechanism of
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864290. PubMed ID: 37476805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9836790. PubMed ID: 38074350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Demographics and Economic Burden of Nasopharyngeal Carcinoma Inpatients.
    International BR
    Biomed Res Int; 2023; 2023():9850320. PubMed ID: 38188831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.